US 11,929,158 B2
User interface for diabetes management system
Bryan Mazlish, Palo Alto, CA (US); Jeffrey Brewer, Menlo Park, CA (US); Lane Desborough, Thousand Oaks, CA (US); Jennifer Block, Menlo Park, CA (US); Robert Weishar, Daly City, CA (US); and Alan Schachtely, Dublin, CA (US)
Assigned to Insulet Corporation, Acton, MA (US)
Filed by Insulet Corporation, Acton, MA (US)
Filed on Mar. 21, 2019, as Appl. No. 16/360,751.
Application 16/360,751 is a continuation of application No. 15/402,493, filed on Jan. 10, 2017, granted, now 10,275,573.
Claims priority of provisional application 62/278,231, filed on Jan. 13, 2016.
Prior Publication US 2019/0221307 A1, Jul. 18, 2019
This patent is subject to a terminal disclaimer.
Int. Cl. G16H 20/17 (2018.01); A61M 5/142 (2006.01); A61M 5/172 (2006.01); G16H 20/60 (2018.01); G16H 40/63 (2018.01); G16H 40/67 (2018.01)
CPC G16H 20/17 (2018.01) [A61M 5/14244 (2013.01); A61M 5/1723 (2013.01); G16H 20/60 (2018.01); G16H 40/63 (2018.01); G16H 40/67 (2018.01); A61M 2005/14208 (2013.01); A61M 5/14276 (2013.01); A61M 2005/14288 (2013.01); A61M 2205/18 (2013.01); A61M 2205/3303 (2013.01); A61M 2205/3523 (2013.01); A61M 2205/3569 (2013.01); A61M 2205/3584 (2013.01); A61M 2205/50 (2013.01); A61M 2205/502 (2013.01); A61M 2205/581 (2013.01); A61M 2205/582 (2013.01); A61M 2205/583 (2013.01); A61M 2230/201 (2013.01)] 27 Claims
OG exemplary drawing
 
1. A mobile computing device for controlling a medical infusion pump system, the computing device comprising:
a display screen of a smart phone or a tablet computer;
one or more input controls manipulable by a user;
one or more processors;
a memory to store computer-readable instructions that, when executed by the one or more processors, enable the computing device to perform actions comprising:
communicating with a controller of a medical infusion pump system to cause the medical infusion pump system to dispense medicine to a patient;
receiving blood glucose level information for the patient, wherein the blood glucose level information is associated with one or more blood glucose measurement times;
providing a graphic user interface formatted for the display screen of the smart phone or the tablet computer, wherein the graphical user interface includes:
a blood glucose level chart presented at a first region of the graphical user interface, the blood glucose level chart depicting a series of blood glucose values included in the received blood glucose level information, the series of blood glucose values being aligned adjacent a first vertical axis and over a first time axis to reflect the times that the blood glucose values were measured; and
an insulin delivery chart presented at a second region of the graphical user interface, the insulin delivery chart depicting (1) a first graph, presented at a first sub-region of the second region, showing a continuous line indicating basal delivery rates administered by the infusion pump system over time aligned adjacent a second vertical axis, and (2) a second graph, presented at a second sub-region of the second region, showing a series of insulin bolus indicators indicating times that insulin bolus deliveries were administered aligned adjacent a third vertical axis, respective areas defined by borders of bolus indicators representative of amounts of insulin bolus deliveries, wherein the first graph showing the continuous line indicating basal delivery rates and the second graph showing the series of insulin bolus indicators are aligned over a second time axis, wherein the first graph and the second graph presented at the first and second sub-regions, respectively, do not overlap, wherein the first and third vertical axis are aligned over the same portion of the second time axis,
wherein the second time axis is distinct from the first time axis,
wherein there is no spatial overlap between the blood glucose level chart and the insulin delivery chart,
a current time; and
a vertical line segment that intersects the first time axis and the second time axis respectively at points corresponding to the current time.